Table 3.

%OxHSA and CRTAC1 levels in the low-mRS and high-mRS score groups over a 7-day period.

Sampling	Biomarker	mRS <2 (n = 48)	mRS ≥ 2 (n = 26)	p -value
		Ave. (95% CI)	Ave. (95% CI)
Day 0	%OxHSA	40.2 (38.9–41.4)	42.7 (40.8–44.5)	*0.027
	CRTAC1 (ng/mL)	171.4 (14.4–195.4)	216.6 (175.0–258.3)	0.061
Day 1	%OxHSA	39.0 (37.8–40.1)	41.6 (39.9–43.3)	*0.013
	CRTAC1 (ng/mL)	246.5 (208.5–284.6)	316.3 (250.2–382.5)	0.068
Day 7	%OxHSA	39.1 (38.0–40.3)	41.7 (40.2–43.1)	**0.007
	CRTAC1 (ng/mL)	246.7 (217.1–276.4)	328.2 (271.6–384.7)	*0.013
Day 1–7	Δ OxHSA (%)	−1.1 (−2.0 to −0.2)	−1.0 (−2.5 to −0.6)	0.870
	Δ CRTAC1 (ng/mL)	77.0 (52.6–101.5)	111.5 (56.0–167.0)	0.251

OxHSA, oxidized albumin; CRTAC1, cartilage acidic protein-1.

^*p < 0.05;

^**p < 0.01.